Top Markets
#1 SAFEcoin SAFEcoin +32.96%
#2 Zora Zora +29.77%
#3 AI XOVIA AI XOVIA +22.03%
#4 Helium Helium +21.85%
#5 Full Moon Full Moon +19.85%
#6 Merlin's Seal BTC Merlin's Seal BTC +16.10%
#7 0G 0G +15.13%
#8 Axelar Axelar +14.88%
#9 VVS Finance VVS Finance +13.70%
#10 rsERG rsERG +12.24%
Coin of the day
SAFEcoin SAFEcoin
Settings
Language
ENGLISH
Currency
USD
Theme
Graphite Bio, Inc. Graphite Bio, Inc.

Graphite Bio, Inc.

GRPH
Rank in Stocks #12751
Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to... Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the glucocerebrosidase enzyme. Initially established as Integral Medicines, Inc., the company rebranded to Graphite Bio, Inc. in August 2020. Founded in 2017, Graphite Bio's operations are based out of its headquarters in South San Francisco, California.
Share Price
$22.26
Last synced: 2024-03-22
Market Cap
$553.40M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Graphite Bio, Inc. (GRPH)

Category

Healthcare
Number of shares outstanding for Graphite Bio, Inc. (GRPH)
Number of shares outstanding as of August 2026: 0
According to Graphite Bio, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Graphite Bio, Inc. (GRPH) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH